This Discovery is Expected to Pave the Way for Metabolomic Profiling in the Monitoring and Treatment of Cancer SAN DIEGO, CA – February 23, 2017 – CureMatch, the developer of a decision support platform for combination therapy in cancer, revealed in the 2nd Annual Biomarker Conference new discoveries using metabolomics as a tool for clinical […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.